Interventional Neuroradiology Market

Interventional Neuroradiology Market is valued at USD 2305.2 Million in 2021 and expected to reach USD 3425.2 Million by 2028 with a CAGR of 5.82% over the forecast period.

The increasing preference for minimally invasive procedures with the growing prevalence of chronic diseases are driving the Global Interventional Neuroradiology Market.

Market Analysis of Interventional Neuroradiology

Interventional Neuroradiology (INR) is also known as neuro endovascular therapy and is a medical sub-domain of radiology specifying slightly offensive image-based techniques and procedures used in diagnosis and treatment of diseases related to neck, head and spine. This therapy is focusing on the diagnosis and characterization of abnormalities of the peripheral and central nervous system, head, spine and neck by using neuroimaging techniques. Interventional neurology has undergone a prompt evolution in past 2-3 decades due to the continuing advances in imaging technology and the introduction of new tools, including more traceable microcatheters and safer embolic materials. Currently, neuroradiological techniques play vital roles in the diagnosis of brain arteriovenous malformation (AVM), cerebral aneurysm, Carotid-cavernous fistula (CCF), head and neck tumors, meningioma, nosebleeds, strokes and vertebral body tumors. As compared to open surgical methods, this method offers minimally invasive substitutes for various head and neck disorders. The head and neck interventions can be executed through percutaneous, endovascular or an arrangement of these two.

Interventional Neuroradiology Companies-

Some major key players for interventional neuroradiology market are -

• Allina Health
• Balt Extrusion
• Boston Scientific Corporation
• Codman neuro
• DePuy Synthes
• Fujifilm Healthcare
• GE Healthcare
• Gore & Associates
• Medtronic
• Merit Medical Systems
• MicroPort Scientific Corporation
• Penumbra Inc.
• Siemens Healthineers
• Stryker
• Terumo Corporation
• Others

Interventional Neuroradiology Market Segmentation-

Interventional Neuroradiology market report is segmented on the basis of product, disease, end-user and region & country level. Based upon product, interventional neuroradiology market is segmented into neurovascular embolization and coiling assist devices, embolic coils, flow diversion devices, liquid embolic agents, accessories, micro catheters, microguidewires and others. Based on disease, market is segmented into cerebral aneurysms, intra-cranial tumors, acute strokes and other. Based upon end-user, interventional neuroradiology market is segmented into hospitals, ambulatory surgical centers and others.

By Product

• Neurovascular Embolization and Coiling Assist Devices
• Embolic Coils
• Flow Diversion Devices
• Liquid Embolic Agents
• Accessories
• Micro catheters
• Micro guidewires

By Disease

• Cerebral Aneurysms
• Intra-Cranial Tumors
• Acute Strokes
• Other

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Other

By Regional & Country Analysis:

• North America

• U.S.
• Mexico
• Canada

• Europe

• UK
• France
• Germany
• Italy

• The Asia Pacific

• China
• Japan
• India
• Southeast Asia

• South America

• Brazil,
• Argentina
• Columbia

• The Middle East and Africa

• GCC
• Africa
• Rest of the Middle East and Africa

Market Dynamics of Interventional Neuroradiology -

Increasing technological advancements in neuroradiology such as; developments of different microcatheters, embolic agents, guidewires, high resolution imaging tools and therapeutic techniques is the major factor driving the growth of market. In addition, increasing preference for minimally invasive procedures with the growing incidences of chronic diseases, increase in geriatric population are some of the factors that are supporting the growth of the market. High demand for MI (multiple imputations) procedures is also playing a supportive role in the market growth. However, long term therapeutic efficiency or risk benefit calculations in microsurgery, deficiency of IR consultants in the field of neuroradiology and entry hurdles for new players are the factors which may act as the barriers for market growth.

Moreover, rapid progress in neuroradiology has provided the new therapeutic applications in the difficult diseases of brain and neck, steady and objective evaluation in neuroradiology which can create new revenue opportunities for the interventional neuroradiology market.

Regional Analysis of Interventional Neuroradiology Market:

The interventional neuroradiology market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America is expected to dominate the interventional neuroradiology market owing to the cost effective diagnosis, growing occurrence of chronic diseases and high demand of minimally invasive technologies in this region. Additionally, high acceptance of technologically advanced medical devices and well established healthcare groundwork are supporting the growth in North America. Asia-Pacific is expecting to be the fastest region within forecast period due to the swift developments in healthcare infrastructure in the emerging economies such as India and china.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2021:	USD 2305.2 Million
Base year considered	2020
Forecast Period CAGR %:	5.82%
Market Size Expected in 2028:	USD 3425.2 Million
Tables, Charts & Figures:	175
Pages	300
Companies	Allina Health, Balt Extrusion, Boston Scientific Corporation, Codman neuro, DePuy Synthes, Fujifilm Healthcare, GE Healthcare, Gore & Associates, Medtronic, Merit Medical Systems, MicroPort Scientific Corporation, Penumbra Inc., Siemens Healthineers, Stryker, Terumo Corporation, Others..
Segments Covered	By Product, By Disease, By End-User
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa